Cancer Epidemiol Biomarkers Prev 13(2):171–180PubMedCrossRef Mill

selleck Cancer Epidemiol Biomarkers Prev 13(2):171–180PubMedCrossRef Miller SM, Daly MB, Sherman KA, Fleisher L, Buzaglo JS, Stanton L, Godwin AK, Scarpato J (2006) Psychosocial proceses in genetic risk

assessment for breast cancer. In: Miller SM, McDaniel SH, Rolland JS, Feetham SL (eds) Individuals, families, and the new era of genetics. W. W. Norton & Company, New York, pp 274–319 Miller SM, Fang CY, Manne SL, Engstrom PF, Daly MB (1999) Decision making about prophylactic oophorectomy among at-risk women: psychological influences and implications. Gynecol Oncol 75(3):406–412PubMedCrossRef Miller SM, Fleisher L, Roussi P, Buzaglo JS, Schnoll R, Slater E, Raysor S, Popa-Mabe M (2005a) Facilitating informed decision making about breast cancer risk and genetic counseling 17DMAG in vivo among women calling the NCI’s Cancer Information Service. J Heal Commun 10(Suppl 1):119–136. doi:10.​1080/​0736629050026533​5 CrossRef Miller SM, Roussi P, Daly MB, Buzaglo JS, Sherman K, Godwin AK, Balshem A, Atchison ME (2005b) Enhanced counseling for women undergoing BRCA1/2 testing: impact on subsequent selleck chemicals decision making about risk reduction behaviors. Heal Educ Behav 32(5):654–667. doi:10.​1177/​1090198105278758​

CrossRef Miller SM, Roussi P, Daly MB, Scarpato J (2010) New strategies in ovarian cancer: uptake and experience of women at high risk of ovarian

cancer who are considering risk-reducing salpingo-oophorectomy. Clin Cancer Res 16(21):5094–5106. doi:10.​1158/​1078-0432.​ccr-09-2953 PubMedCentralPubMedCrossRef Miller SM, Shoda Y, Hurley K (1996) Applying cognitive-social theory to health-protective behavior: breast self-examination in cancer screening. Psychol Bull 119(1):70–94PubMedCrossRef NADPH-cytochrome-c2 reductase Nanda R, Schumm LP, Cummings S, Fackenthal JD, Sveen L, Ademuyiwa F, Cobleigh M, Esserman L, Lindor NM, Neuhausen SL, Olopade OI (2005) Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. JAMA 294(15):1925–1933PubMedCrossRef Olopade OI, Fackenthal JD, Dunston G, Tainsky MA, Collins F, Whitfield-Broome C (2003) Breast cancer genetics in African Americans. Cancer 97(1 Suppl):236–245PubMedCrossRef Pal T, Permuth-Wey J, Holtje T, Sutphen R (2004) BRCA1 and BRCA2 Mutations in a study of African American breast cancer Patients. Cancer Epidemiol Biomarkers Prev 13(11):1794–1799PubMed Patenaude AF (2005) Genetic testing for cancer: psychological approaches for helping patients and families.

Comments are closed.